NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Stock Cash Flow
Europe - BIT:1NBIX - US64125C1099 - Common Stock
120.05 EUR
+120.05 (+Infinity%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 348.30M | 341.30M | 249.70M | 154.50M | 89.60M | |||
| Depreciation Amortization | 28.50M | 27.10M | 21.30M | 15.60M | 10.90M | |||
| Income Taxes - Deferred | -117.30M | -123.10M | -56.70M | 19.10M | 4.30M | |||
| Change In Working Capital | 35.90M | -19.20M | 28.20M | -67.40M | 16.70M | |||
| Interest Paid | N/A | 1.60M | 3.80M | 6.60M | 8.60M | |||
| Taxes Paid | 197.20M | 217.50M | 51.50M | 14.40M | 5.10M | |||
| Other non cash items | 271.90M | 369.30M | 147.40M | 217.60M | 135.00M | |||
| OPERATING CASH FLOW | 567.30M | 595.40M | 389.90M | 339.40M | 256.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -38.60M | -38.20M | -28.30M | -16.50M | -23.40M | |||
| Other Investing Activity | -19.80M | -88.60M | -438.80M | -160.60M | -106.80M | |||
| INVESTING CASH FLOW | -58.40M | -126.80M | -467.10M | -177.10M | -130.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -308.80M | N/A | -279.00M | -100.00K | |||
| Stock Issued/Repurchased | -384.80M | -177.90M | 65.30M | 44.70M | 27.50M | |||
| FINANCING CASH FLOW | -384.80M | -486.70M | 65.30M | -234.30M | 27.40M | |||
| Exchange Rate Effect | N/A | 0.00 | 300.00K | -1.30M | N/A | |||
| CHANGE IN CASH | 124.30M | -18.10M | -11.60M | -73.30M | 153.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 567.30M | 595.40M | 389.90M | 339.40M | 256.50M | |||
| Capital Expenditure | -38.60M | -38.20M | -28.30M | -16.50M | -23.40M | |||
| FREE CASH FLOW | 528.70M | 557.20M | 361.60M | 322.90M | 233.10M | |||
All data in USD